• Event // 08.16.2020

2M Clinical is presenting at MassBio Digital Health Impact Conference 2020

Recruitment and enrollment of diverse participants into clinical trials can be challenging. Can the telemedicine provide an avenue for clinical trials to be more inclusive and accessible?  On September 30, 2020, 2M Clinical’s SVP and Chief Medical Officer, Dr. Regina James will discuss “how telemedicine can enhance recruitment and enrollment of diverse populations into clinical trials” at the MassBio Digital Health Impact Conference 2020. MassBio represent the premier global life sciences and healthcare hub, with 1,300+ members dedicated to preventing, treating, and curing diseases through transformative science and technology that brings value and hope to patients.

For more information, please visit the Digital Health Impact Conference website here.